2020 Behavioral Medicine Symposium Enduring: Marijuana and Psychiatric Disorders


Products You May Like


Target Audience
This activity is targeted toward all primary care and psychiatry providers.

Statement of Need
Providers need to be versed on behavioral health integration in primary care, caring for patients with substance abuse disorder, and correct diagnosis and treatment of psychiatric and mental health disorders.

At the conclusion of this offering, the participant will be able to:
1) Review current information on marijuana use in the United States.
2) Discuss mental illness, mental disorders and marijuana/cannabis use.
3) Discuss and review current evidence for medical marijuana in the treatment of psychiatric disorders.

Christopher M. Stewart, M.D.
Associate Professor, Department of Psychiatry
University of Louisville School of Medicine

Faculty Disclosure
Faculty for this course has no conflicts of interest to disclose.

Planner Disclosure
No planners for this course have conflicts of interest to disclose.

Physician Credits
Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.
Norton Healthcare designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Kentucky Board of Nursing (KBN) Credits
Kentucky Board of Nursing (KBN) Approved Provider: Norton Healthcare, provider number 4-0002-12-20-251. The program has been approved by Norton Healthcare for 0.9 contact hours which expires 12/31/2020. KBN approval of a continuing education provider does not constitute endorsement of program content. Nursing participants must attest to the number of hours of attendance and complete the evaluation to receive contact hours.

Date of Original Release | June 2020
Course Termination Date | December 2021
Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org

Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders
Marijuana Use is Associated with Worse Outcomes in Symptom Severity and Violent Behavior in Patients with PTSD
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis

Products You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *